Morris Tweed

423 total citations
11 papers, 161 citations indexed

About

Morris Tweed is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Morris Tweed has authored 11 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 2 papers in Organic Chemistry. Recurrent topics in Morris Tweed's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Chemical Synthesis and Analysis (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Morris Tweed is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Chemical Synthesis and Analysis (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Morris Tweed collaborates with scholars based in United Kingdom, Switzerland and Singapore. Morris Tweed's co-authors include Robert B. Wallis, John Ambler, Kevin Mitchell, K. Butler, Keith Butler, Keith Menear, David J. Bentley, Peter C. Butler, Derek E. Brundish and Clive McCarthy and has published in prestigious journals such as Thrombosis and Haemostasis, Bioorganic & Medicinal Chemistry Letters and Pathophysiology of Haemostasis and Thrombosis.

In The Last Decade

Morris Tweed

9 papers receiving 146 citations

Peers

Morris Tweed

HEMAT

CCM

SURGE

Ryo Iwamura Japan

Tom-Philipp Zucker Germany

Shinya Aoki Japan

Yoshitaka Yoshizawa Japan

Ruth Fernández‐Sánchez Spain

Sandra P. D’Angelo Italy

Anne Marie Venneröd Norway

Catherine Borg United Kingdom

H. Jensen United States

Laiq Chaudry United Kingdom

Ryo Iwamura Japan

Morris Tweed

15 ×0.2

HEMAT

68 ×1.6

71 ×1.8

CCM

10 ×0.3

27 ×0.9

SURGE

Citations per year, relative to Morris Tweed Morris Tweed (= 1×) peers Ryo Iwamura

Countries citing papers authored by Morris Tweed

Since Specialization

Citations

This map shows the geographic impact of Morris Tweed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Tweed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Tweed more than expected).

Fields of papers citing papers by Morris Tweed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morris Tweed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Tweed. The network helps show where Morris Tweed may publish in the future.

Co-authorship network of co-authors of Morris Tweed

This figure shows the co-authorship network connecting the top 25 collaborators of Morris Tweed. A scholar is included among the top collaborators of Morris Tweed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morris Tweed. Morris Tweed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Press, Neil J., Roger Taylor, Pamela Tranter, et al.. (2005). A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential. Bioorganic & Medicinal Chemistry Letters. 15(12). 3081–3085. 25 indexed citations

Kane, Peter D., Keith Menear, Ric N. Price, et al.. (2000). the design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(14). 1567–1570. 9 indexed citations

Brundish, Derek E., C. P. Dell, Peter D. Kane, et al.. (2000). The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position. Bioorganic & Medicinal Chemistry Letters. 10(14). 1563–1566. 8 indexed citations

Ambler, John, et al.. (1999). The discovery of orally available thrombin inhibitors: Optimisation of the P1 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 9(8). 1103–1108. 6 indexed citations

Ambler, John, Emma L. Baker, Keith Butler, et al.. (1999). Studies towards the identification of potent, selective and bioavailable thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(5). 737–742. 6 indexed citations

Ambler, John, Emma L. Baker, Peter C. Butler, et al.. (1998). The Discovery of orally available thrombin inhibitors : Studies towards the optimisation of CGH1668. Bioorganic & Medicinal Chemistry Letters. 8(24). 3583–3588. 8 indexed citations

Ambler, John, et al.. (1991). The Effects of Recombinant Desulphatohirudin on Arterial Thrombosis in Rats. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 73–79. 9 indexed citations

Mitchell, Kevin, et al.. (1991). The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.. PubMed. 65(3). 268–74. 44 indexed citations

Ambler, John, et al.. (1989). Recombinant Desulphatohirudin (CGP 39393) Anticoagulant and Antithrombotic Properties In Vivo. Thrombosis and Haemostasis. 61(1). 77–80. 45 indexed citations

10.

Jasani, M K, G. P. Lewis, & Morris Tweed. (1974). Proceedings: A new approach for studying the anti-rheumatic activity of indomethacin using the homograft reaction as a model for chronic immunologically-mediated inflammation.. PubMed. 50(3). 475P–475P. 1 indexed citations

11.

Jasani, M K, et al.. (1974). Proceedings: The usefulness of homologous pairs of rabbit skin grafts for studying the pharmacology of anti-rheumatic agents.. PubMed. 51(1). 152P–152P.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact